68Ga-PSMA PET in the Renal Cell Carcinoma
Condition(s):Renal Cancer; Metastases; PSMA PETLast Updated:January 26, 2024Recruiting
Hide Studies Not Open or Pending
Condition(s):Renal Cancer; Metastases; PSMA PETLast Updated:January 26, 2024Recruiting
Condition(s):Renal Cell CarcinomaLast Updated:September 28, 2023Completed
Condition(s):Kidney CancerLast Updated:May 30, 2017Terminated
Condition(s):NK Cell Mediated Immunity; NK Cell Cytokine Production; Kidney CancerLast Updated:September 21, 2021Completed
Condition(s):Clear Renal Cell Cancer (< 7cm Size)Last Updated:September 17, 2019Unknown status
Condition(s):Melanoma; Renal Cell CarcinomaLast Updated:May 8, 2023Active, not recruiting
Condition(s):Advanced/ Metastatic Renal Cell CancerLast Updated:December 21, 2020Completed
Condition(s):Carcinoma, Renal CellLast Updated:August 19, 2019Unknown status
Condition(s):Renal Tumor Histology; Kidney Cancer; Renal Cell Carcinoma; Familial Renal Cancer; HLRCC; VHL Syndrome; BAP1 Tumor Predisposition Syndrome; FLCN Gene Mutation; ALK Gene Mutation; FH Gene Mutation; Birt-Hogg-Dube Syndrome; MET Gene Mutation; Cutaneous Leiomyoma; Cutaneous Leiomyomata With Uterine LeiomyomataLast Updated:August 31, 2023Recruiting
Condition(s):Renal Cell CancerLast Updated:July 16, 2020Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.